
Blog
Blog Posts
- Previous
- 1–10 of 13
- Next
Young Blood Transfusions Are All Hype
EU Temporarily Suspends Essure Implants

The sale and implantation of the permanent birth control device, Essure, which has led to the death of at least four women and causes pain so severe some women report becoming suicidal, has been suspended in the EU for three months pending additional information.
Asyra Machines Can't Diagnose Anything

FDA Issues Warning About Homeopathic Diet Aid
The Food and Drug Administration (FDA) is warning consumers to stay away from "homeopathic" human chorionic gonadotropin (HCG) weight loss products that are sold in the form of oral drops, pellets and sprays. They can be purchased online or in retail stores.
FDA Expects Recall of Popular Foods to Grow
by Susan Brinkmann, OCDS
Staff Journalist
The Food and Drug Administration (FDA) announced yesterday that the recall of popular food products containing salmonella-infected hydrolyzed vegetable protein (HVP), which includes foods from Pringles to Herr’s Potato chips, is likely to expand.
FDA Delays Human Trials of Embyonic Stem Cells
By Susan Brinkmann, OCDS
Staff Writer
The Food and Drug Administration (FDA) is delaying a bid by biotech company Geron Corp. to become the first to conduct human trials with embryonic stem cells, pending review of new studies.
FDA Warns Consumers to Stop Using Popular Cold Medicine
By Susan Brinkmann, OCDS
Staff Writer
The Food and Drug Administration (FDA) is warning consumers to stop using the popular homeopathic cold remedy, Zicam, because of hundreds of reports of people losing their sense of smell after using the product.
FDA to Slow Down Use of Adult Stem Cells
By Susan Brinkmann, OCDS
Staff Writer
One of the nation’s leading adult stem cell therapy organizations is warning the public that the Food and Drug Administration (FDA) is teaming up with the nation’s pharmaceutical industry to declare a person’s own stem cells to be a “drug” which can be regulated, thus slowing down the use of these therapies by requiring years of clinical trials before they can be used.
FDA Allows Minors Access to Emergency Contraception
By Susan Brinkmann, OCDS
Staff Writer
In a move that surprised no one, the Food and Drug Administration (FDA), decided not to appeal a federal judge’s order to remove restrictions on over-the-counter access to the emergency contraception drug known as “Plan B” which will now allow 17 year-olds to access the drug.
- Previous
- 1–10 of 13
- Next